Abstract 2910: Selenium nanoparticles suppress prostate LNCaP cancer cells growth through induced endogenous apoptosis

Abstract

Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Prostate cancer has the highest incidence in all kinds of cancers in males.Recent reports suggest androgen receptor (AR) plays a critical role in prostate cancer development.The trace element Selenium is suggested having cancer prevention activity and used as food supplement. Here, we investigated inherent anticancer mechanisms of Selenium nanoparticles. We found Selenium nanoparticles inhibit growth of prostate LNCaP cancer cells partially through caspases mediated apoptosis. Selenium nanoparticles suppress transcriptional activity of androgen receptor via down-regulating its mRNA and protein expression. Moreover, Selenium nanoparticles activate Akt kinase by increasing its phosphorylation, promote Akt-dependent androgen receptor phosphorylation and Mdm2 regulated degradation through proteasome pathway. Together, we suggest Selenium nanoparticles suppress prostate cancer cells growth by disrupting androgen receptor, implicating a potential application in cancer treatment. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2910. doi:1538-7445.AM2012-2910